Clinical research

The first clinical experience with the new GORE® septal occluder (GSO)

EuroIntervention 2013;9:959-963 published online ahead of print June 2013. DOI: 10.4244/EIJV9I8A160

Lars Søndergaard1*, MD; Poay Huan Loh1,2, MD; Olaf Franzen1, MD; Nikolaj Ihlemann1, MD; Niels Vejlstrup1, MD

1. The Heart Center, Rigshospitalet University Hospital, Copenhagen, Denmark; 2. Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom

Aims: A new GORE® septal occluder (GSO) was granted CE mark in Europe in June 2011 for the treatment of

No account yet? Sign up for free!

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

atrial septal defectscongenital defectspatent foramen ovaleseptal occluder device

Latest news